This reference uses the specific documents linked in the article and listed below. Check their scope, publication dates and the statements they support.
Poor night vision reflects retinal signaling rather than stubbornness
The retina must translate light into signals the brain can use. CSNB disrupts the low-light pathway, so an affected horse may have difficulty finding a feed bucket, crossing a dark doorway or moving through unfamiliar space at night. Daylight performance can conceal the deficit.
Fear or hesitation in these settings should not simply be punished as disobedience. The horse may be unable to see the expected route. A veterinary eye assessment helps distinguish a congenital signaling disorder from pain, acquired retinal disease or another cause of apparently inconsistent behavior.
Source: Congenital stationary night blindness; Genetic cause of night blindness confirmed in Tennessee Walking Horses and identified in Standardbreds and Missouri Fox Trotting Horses; Assessment of vision and common eye problems in horses.
Stationary does not mean the horse cannot develop another disease
The congenital defect itself is described as nonprogressive. However, the animal can later develop cataract, trauma, uveitis or another problem that worsens vision. New squinting, tearing, cloudiness or loss of daytime function is not explained simply by an old CSNB diagnosis.
Leopard-complex horses illustrate the distinction because LP-related night blindness and an increased risk of recurrent uveitis can coexist. Uveitis is an inflammatory condition with a different course and treatment. Do not let familiarity with inherited night impairment delay care for a painful eye.
Source: Leopard complex, congenital stationary night blindness, and uveitis; Congenital stationary night blindness; Equine recurrent uveitis.
More than one genetic form needs to be considered
Horses homozygous for LP have the recognized leopard-complex-associated form involving TRPM1. Coat appearance alone is an imperfect substitute for genotype because expression of the spotting pattern varies. Appropriate genetic testing can clarify that inherited form.
UC Davis subsequently confirmed a separate recessive CSNB2 association in Tennessee Walking Horses and affected Standardbred and Missouri Fox Trotting horses. Its genetic basis differs from LP. A negative test for one variant therefore does not automatically rule out every inherited cause of low-light impairment.
Source: Leopard complex, congenital stationary night blindness, and uveitis; Genetic cause of night blindness confirmed in Tennessee Walking Horses and identified in Standardbreds and Missouri Fox Trotting Horses.
Clinical examination and electroretinography answer the vision question
A veterinary ophthalmologist can assess the eye and use electroretinography to evaluate retinal responses. Genetic testing can support diagnosis for the variants relevant to the horse and family. These tools answer different questions: a clinical test examines function, while a variant test identifies a defined inherited change.
Do not deliberately create dangerous obstacles or leave the horse in a novel dark enclosure to demonstrate the problem. Observe ordinary difficulties and seek assessment. Safe handling should begin while the diagnosis is being clarified, especially around loading ramps, gates and changing light levels.
Source: Congenital stationary night blindness; Genetic cause of night blindness confirmed in Tennessee Walking Horses and identified in Standardbreds and Missouri Fox Trotting Horses; Assessment of vision and common eye problems in horses.
Use light, familiarity and predictable routes
Provide suitable lighting where the horse must eat, drink, enter shelter or be handled after dark. Keep important resources and routes consistent and allow time to explore a new environment in daylight. Remove hazards that might be avoided easily by a horse with normal low-light vision.
Any companion arrangement must be compatible and safe; another horse is not a substitute for adequate light and accessible resources. Consider dusk, dark trailers and abrupt transitions into buildings, not only the middle of the night. A well-managed familiar yard can be much safer than relying on the animal to adapt to unpredictable obstacles.
Source: Congenital stationary night blindness; Genetic cause of night blindness confirmed in Tennessee Walking Horses and identified in Standardbreds and Missouri Fox Trotting Horses.
Make breeding decisions from the actual variant and inheritance
The CSNB2 form is recessive in the UC Davis study, so carriers with one copy differed from affected homozygotes. LP has its own genotype and coat-pattern context. Use a veterinarian or genetics adviser to interpret results and avoid producing affected offspring through an uninformed pairing.
Do not label every relative as blind or equate carrier status with a clinical deficit without the relevant genetic interpretation. Test scope and family context matter. The aim is informed breeding and suitable care, not a claim that a negative result for one known variant guarantees perfect vision from all causes.
Source: Genetic cause of night blindness confirmed in Tennessee Walking Horses and identified in Standardbreds and Missouri Fox Trotting Horses; Leopard complex, congenital stationary night blindness, and uveitis.
Practical questions
Will CSNB normally get worse with age?
The same congenital stationary disorder is not expected to progress, but another eye disease can arise and needs its own examination.
Does an LP test cover every night-blindness form?
No. CSNB2 and other possible causes require appropriate test selection and clinical assessment.
Can suitable lighting help?
Yes. Consistent lighting, familiar routes and safe resource access are central management measures.
Should a painful eye be accepted as part of CSNB?
No. Pain suggests another problem and requires prompt veterinary assessment.
Related animal-health reading
Cite this reference
LivestockDefense. “Congenital stationary night blindness in horses: genetics, safe handling and daily care.” Updated 2026-11-02. https://livestockdefense.com/threats/equine-congenital-stationary-night-blindness/
Add the date you accessed the page. This identifies the current reference; keep a permitted saved copy if your work depends on its exact wording. A citation alone does not establish support for a claim.
How to cite a page and its revision ↗Sources & boundaries
Read the evidence in context.
These documents support the statements identified in this reference. Check their scope and dates when deciding whether they answer your question.
- Cornell University College of Veterinary Medicine: Assessment of vision and common eye problems in horses
Source update: 2023-05-15. Most recent check: 2026-11-02.
Condition-specific mechanisms, signs, diagnostic limitations and care principles attributed to this document; no drug dosages or invasive procedures reproduced.
- UC Davis Center for Equine Health: Equine recurrent uveitis
Source update: Not provided. Most recent check: 2026-11-02.
Clinical forms, cumulative damage, genetic/environmental contributions and specialist care categories; fixed outcome percentages and invasive procedures are not reproduced.
- UC Davis Center for Equine Health: Congenital stationary night blindness
Source update: Not provided. Most recent check: 2026-11-02.
Congenital nonprogressive low-light impairment, electroretinography and environmental management; older claims that only LP testing is relevant are qualified by newer CSNB2 findings.
- UC Davis Veterinary Genetics Laboratory: Genetic cause of night blindness confirmed in Tennessee Walking Horses and identified in Standardbreds and Missouri Fox Trotting Horses
Source update: 2023-10-16. Most recent check: 2026-11-02.
Condition-specific mechanisms, signs, diagnostic limitations and care principles attributed to this document; no drug dosages or invasive procedures reproduced.
- UC Davis Veterinary Genetics Laboratory: Leopard complex, congenital stationary night blindness, and uveitis
Source update: Not provided. Most recent check: 2026-11-02.
TRPM1/LP homozygous night-blindness association and distinct ERU risk; no commercial price, turnaround or individual breeding prescription reproduced.
